Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Akso Health Group ADR

Healthcare US AHG

1.34USD
-0.12(8.22%)

Last update at 2026-06-05T20:00:00Z

Day Range

1.341.53
LowHigh

52 Week Range

1.072.50
LowHigh

Fundamentals

  • Previous Close 1.46
  • Market Cap1687.71M
  • Volume13334
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.46234M
  • Revenue TTM14.84M
  • Revenue Per Share TTM0.03
  • Gross Profit TTM 0.15M
  • Diluted EPS TTM-0.48

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -166.27028M -9.09179M -16.71830M -16.71830M -31.06927M
Minority interest 0.49M 0.06M -0.11250M -0.00133M -
Net income -134.97737M -9.45878M -16.84973M -16.84973M -31.55224M
Selling general administrative 3.64M 8.59M 15.39M 15.39M 27.27M
Selling and marketing expenses - 0.17M 0.24M 0.24M 1.09M
Gross profit -0.28153M 0.12M 0.92M 0.92M 1.21M
Reconciled depreciation 2.15M 0.00000M - 0.02M 0.02M
Ebit -3.92297M -9.21914M -15.13362M -15.13362M -27.14973M
Ebitda -1.77318M -8.63804M -15.89577M -15.89577M -27.29948M
Depreciation and amortization 2.15M 0.14M -0.76216M -0.76216M -0.14976M
Non operating income net other - - - - -
Operating income -166.30435M -8.63804M -15.13362M -15.13362M -27.14973M
Other operating expenses 181.08M 11.05M 21.44M 21.44M 28.90M
Interest expense - 0.00000M 0.80M 0.80M 2.15M
Tax provision -30.80115M 0.02M 0.02M 0.13M 0.48M
Interest income - - - - -
Net interest income - 0.00000M 0.00000M -0.80414M -2.15462M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -30.80115M 0.02M 0.13M 0.13M 0.48M
Total revenue 14.78M 2.41M 6.31M 6.31M 1.75M
Total operating expenses 166.02M 8.76M 16.05M 16.05M 28.36M
Cost of revenue 15.06M 2.29M 5.39M 5.39M 0.54M
Total other income expense net 0.03M -0.45375M -1.58468M -1.58468M -3.91954M
Discontinued operations - - 11.84M 11.84M -3.27475M
Net income from continuing ops -135.46913M -9.11678M -13.08404M -16.84973M -31.55224M
Net income applicable to common shares - - -1.35992M -16.85106M -34.82699M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 214.95M 142.02M 50.68M 50.68M 31.69M
Intangible assets 7.88M - - - -
Earning assets - - - - -
Other current assets 6.81M 56.65M 0.89M 0.89M 14.97M
Total liab 15.80M 3.59M 38.39M 38.39M 14.41M
Total stockholder equity 199.12M 138.37M 12.28M 12.28M 17.27M
Deferred long term liab - - - - -
Other current liab 3.52M 1.10M 38.39M 38.39M 4.41M
Common stock 0.17M 0.04M 0.00698M 0.00698M 0.00500M
Capital stock 0.17M 0.04M 0.00698M 0.00698M 0.00500M
Retained earnings -198.90375M -63.92638M -53.10768M -53.10768M -36.25661M
Other liab - - - - -
Good will 10.83M - - - -
Other assets - -0.40290M - - 1.50M
Cash 176.23M 85.17M 21.93M 21.93M 15.13M
Cash and equivalents - - - - -
Total current liabilities 13.81M 3.59M 38.39M 38.39M 14.41M
Current deferred revenue 10.22M 0.42M 0.19M - -
Net debt -176.14814M -85.17402M -21.92532M -21.92532M -5.12872M
Short term debt 0.04M 2.00M - - 10.00M
Short long term debt - - - - 10.00M
Short long term debt total 0.08M 2.00M - - 10.00M
Other stockholder equity 401.63M 206.34M 67.03M 67.03M 56.63M
Property plant equipment - - - 0.06M 0.07M
Total current assets 196.12M 142.02M 50.62M 50.62M 30.12M
Long term investments - - - - 0.00000M
Net tangible assets - - 8.73M 12.28M 17.27M
Short term investments - - - - -
Net receivables 12.90M 56.25M 20.02M 20.02M 14.40M
Long term debt - - - - -
Inventory 0.19M 0.19M 7.80M 7.80M -14.37263M
Accounts payable - -2.00000M - - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3.77137M -4.08659M -1.64922M -1.64922M -3.10354M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - -141.61522M -0.27213M - 1.50M
Deferred long term asset charges - - - - -
Non current assets total 18.83M 0.40M 0.06M 0.06M 1.56M
Capital lease obligations 0.08M - - - 0.00000M
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -105.91269M -54.72108M 18.47M -19.96386M -0.00066M
Change to liabilities - - 0.71M -0.10424M -0.08210M
Total cashflows from investing activities -105.91269M -54.72108M 18.47M -19.96386M -0.00066M
Net borrowings 0.00000M -7.68615M -27.51385M 24.76M -9.07416M
Total cash from financing activities 195.88M 131.65M 34.78M 34.78M -9.03722M
Change to operating activities - - 0.10M 5.51M 20.88M
Net income -135.46913M -9.11678M -16.84973M -16.84973M -34.71704M
Change in cash 90.03M 77.01M 6.80M 6.80M 4.20M
Begin period cash flow 86.20M 9.19M 15.13M 15.13M 10.93M
End period cash flow 176.23M 86.20M 21.93M 21.93M 15.13M
Total cash from operating activities 1.18M 1.35M -8.62837M -8.62837M 10.06M
Issuance of capital stock 195.88M 139.34M 0.00000M 10.02M -
Depreciation 2.15M 0.00000M 0.02M 0.02M 0.02M
Other cashflows from investing activities -12.00823M -54.72108M - - -0.40808M
Dividends paid - - - - 0.00000M
Change to inventory 0.00000M 1.50M -7.79582M -7.79582M 20.52M
Change to account receivables -0.85954M 0.33M 0.01M 0.01M -0.02543M
Sale purchase of stock - - - 0.00000M 0.00000M
Other cashflows from financing activities - 131.65M 34.76M 34.76M 0.96M
Change to netincome - - -0.72035M 10.77M 23.76M
Capital expenditures 0.15M 0.00000M 0.00486M 0.00486M 0.00486M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 3.02M 2.06M -2.56415M -2.56415M 21.11M
Stock based compensation - 0.00000M 0.39M 0.39M 0.06M
Other non cash items 162.28M 8.41M 10.38M 10.38M -3.16480M
Free cash flow 1.02M 1.35M -8.63323M -8.63323M 10.06M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHG
Akso Health Group ADR		 -0.12 8.22% 1.34 - - 113.71 8.64 114.70 -0.3914
COR
Cencora Inc.		 4.72 1.75% 275.04 37.46 17.70 0.19 31.84 0.20 17.10
MCK
McKesson Corporation		 18.71 2.47% 775.66 17.95 14.53 0.20 5.04 0.22 12.17
CAH
Cardinal Health Inc		 3.97 1.97% 205.71 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 1.15 1.51% 77.45 24.12 14.04 0.74 2.50 0.95 13.33

Reports Covered

Stock Research & News

View All

Profile

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Akso Health Group ADR

Qiantongyuan Building, Qingdao, China

Key Executives

Name Title Year Born
Ms. Yilin Wang CEO & Chairwomen of the Board NA
Ms. Rui Zhang Chief Financial Officer 1983
Ms. Daisy Wang Investor Relation Contact NA
Ms. Ma Xiaoqin Corp. Sec. NA
Ms. Yilin Wang CEO & Chairwoman of the Board 1987
Ms. Rui Zhang Chief Financial Officer 1984
Ms. Ma Xiaoqin Corporate Secretary NA
Mr. Zhongliang Xie Chief Financial Officer 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.